샘플 요청 목록

 카트 문의
시장보고서
상품코드
1564072

세계의 세포 계수 시장

Cell Counting
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 182 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세포 계수 세계 시장은 2030년까지 220억 달러에 달할 것으로 예상

2023년에 153억 달러로 추정되는 세포 계수 세계 시장은 2023-2030년의 분석 기간 동안 연평균 5.3% 성장하여 2030년에는 220억 달러에 달할 것으로 예상됩니다. 세포 계수 소모품은 이 보고서에서 분석한 부문 중 하나이며, CAGR 6.0%를 기록하여 분석 기간 종료 시점에 129억 달러에 도달할 것으로 예상됩니다. 세포 계수 장비 부문의 성장률은 분석 기간 동안 CAGR 4.5%로 추정됩니다.

미국 시장은 42억 달러, 중국은 CAGR 5.0%로 성장 전망

미국의 세포 계수 시장 규모는 2023년 42억 달러로 추정됩니다. 세계 2위의 경제 대국인 중국은 2030년까지 34억 달러 규모에 도달할 것으로 예상되며, 2023-2030년의 분석 기간 동안 5.0%의 연평균 복합 성장률(CAGR)을 나타낼 것으로 예상됩니다. 다른 주목할 만한 지역 시장으로는 일본과 캐나다가 있으며, 분석 기간 동안 각각 5.2%와 4.1%의 연평균 복합 성장률(CAGR)을 나타낼 것으로 예상됩니다. 유럽에서는 독일이 4.3%의 연평균 복합 성장률(CAGR)로 성장할 것으로 예상됩니다.

세계 셀카운팅 시장 - 주요 동향 및 촉진요인 요약

셀카운팅은 생명공학 및 의학 연구를 어떻게 발전시키고 있는가?

세포 계수는 생명공학, 생명과학 및 의학 연구의 기본 기술로, 세포의 행동, 성장 및 치료에 대한 반응에 대한 중요한 통찰력을 제공합니다. 이 과정에는 주어진 샘플의 세포를 정량화하는 것이 포함되며, 약물 스크리닝에서 세포 생존율 평가부터 세포 배양에서 농도 결정에 이르기까지 다양한 응용 분야에 필수적입니다. 세포 수는 세포 증식률에 대한 이해가 새로운 치료법 개발에 직접적인 영향을 미치는 암 연구와 같은 분야에서 필수적입니다. 또한, 바이오 의약품 제조에서도 안정적인 제품 수율과 품질 관리를 위해 정확한 세포 수가 필요하기 때문에 매우 중요합니다. 또한, 세포 수는 면역학, 미생물학, 혈액학에서 질병의 진행과 치료 중재의 효과를 모니터링하기 위해 널리 사용되고 있습니다. 연구, 진단 및 치료법 개발에서 최신 세포 계수의 정확성과 효율성은 과학적 지식과 의료 기술 혁신의 발전에 매우 중요한 역할을 합니다.

세포 계수 자동화 기술에 대한 수요가 증가하는 이유는 무엇일까요?

자동화된 세포 계수 기술에 대한 수요가 증가하는 이유는 연구와 임상 모두에서 정확성, 효율성 및 확장성에 대한 요구가 증가하고 있기 때문입니다. 수작업 세포 계수는 종종 현미경 하에서 혈구 계수기를 사용하여 이루어지기 때문에 시간이 많이 걸리고, 인위적인 실수가 발생하기 쉬우며, 고처리량 용도에는 적합하지 않습니다. 반면, 자동화된 세포 계수 시스템은 빠르고 정확하며 반복 가능한 결과를 제공하여 연구자와 임상의가 대량의 샘플을 훨씬 더 짧은 시간 내에 처리할 수 있게 해줍니다. 이러한 시스템은 수백에서 수천 개의 샘플에서 세포의 생존율과 증식을 신속하게 분석할 수 있는 능력이 약물 발견 및 개발에 필수적인 제약 연구에 특히 유용합니다. 또한, 특히 종양학, 줄기세포 연구, 재생의학 등의 분야에서 생물학적 연구의 복잡성이 증가함에 따라 세포 기반 실험 증가에 대응할 수 있는 보다 정교한 도구가 필요합니다. 고급 이미징 및 유세포 분석 기능을 갖춘 자동 세포 계수기는 고해상도 데이터를 제공하고 이종 세포 집단을 포함하는 복잡한 분석을 지원함으로써 이러한 요구에 부응하고 있습니다. 사용자 친화적인 소프트웨어 인터페이스와 데이터 분석 도구의 통합은 이러한 시스템의 매력을 더욱 높여 전 세계 실험실과 병원에서의 채택을 촉진하고 있습니다.

기술의 발전은 세포 계수 기술을 어떻게 변화시키고 있는가?

기술의 발전은 세포 계수를 변화시키고 있으며, 연구자와 임상의가 사용할 수 있는 도구의 정확도와 기능을 모두 향상시키고 있습니다. 유세포 분석, 이미지 기반 세포 계수, 마이크로플루이딕스 장치 등의 혁신으로 보다 정밀하고 높은 처리량의 세포 분석이 가능해졌습니다. 특히 유세포 분석은 수천 개의 세포를 동시에 계수하고 물리적, 화학적 특성에 따라 특성화할 수 있어 면역페노타이핑 및 암 연구와 같은 응용 분야에 적합합니다. 이미지 기반 세포 계수는 첨단 현미경과 소프트웨어 알고리즘을 사용하여 세포 이미지를 분석하는 것으로, 세포 형태와 생존율에 대한 상세한 데이터를 제공할 수 있어 점점 더 인기를 얻고 있습니다. 또한, 색소나 염색 없이도 세포 증식을 실시간으로 모니터링할 수 있는 무표지 기술의 등장으로 연구 대상 세포에 대한 외부 약물의 영향을 줄이고 세포의 자연스러운 거동을 유지할 수 있게 되었습니다. 인공지능(AI)과 머신러닝을 도입한 자동화 시스템은 세포 계수 기술의 능력을 더욱 향상시켜 대규모 데이터 세트를 기반으로 세포의 거동을 보다 정확하게 예측하고 분석할 수 있게 해줍니다. 이러한 기술 혁신으로 인해 세포 계수는 더욱 빠르고, 신뢰할 수 있으며, 범용성이 높아져 연구 및 임상 진단에 대한 적용이 확대되고 있습니다.

세포 계수 시장의 주요 성장 촉진요인은 무엇인가?

세포 계수 시장의 성장은 만성 질환 증가, 생명 공학의 발전, 개인 맞춤형 의료에 대한 수요 증가 등 여러 가지 요인에 의해 촉진되고 있습니다. 주요 촉진요인 중 하나는 질병 연구 및 진단에서 정확한 세포 분석에 대한 요구가 증가하고 있다는 점입니다. 전 세계적으로 암, 당뇨병, 감염성 질환의 발병률이 지속적으로 증가함에 따라, 세포 계수 기술은 질병의 진행을 모니터링하고 치료 효과를 평가하는 데 필수적입니다. 또한, 바이오 제약 산업, 특히 생물학적 제제 및 백신 제조의 확대로 인해 일관된 제품 품질을 보장하기 위한 정밀한 세포 계수에 대한 수요가 증가하고 있습니다. 자동화된 고처리량 세포 계수 시스템의 개발과 같은 기술 발전은 연구 워크플로우의 속도와 정확성을 향상시켜 시장 성장을 더욱 촉진하고 있습니다. 환자 개개인의 맞춤 치료를 위해 정밀한 세포 분석이 필요한 개인 맞춤형 의료에 대한 관심이 높아지면서 첨단 세포 계수 기술에 대한 수요도 증가하고 있습니다. 또한, 재생의학에서 줄기세포의 사용 증가와 의약품 개발에서 세포 기반 분석의 확대는 세포 계수 솔루션에 대한 새로운 기회를 창출하고 있습니다. 마지막으로, 임상 진단, 특히 혈액학 및 면역학 분야에서 세포 계수 기술의 채택은 의료 서비스 제공업체가 환자 치료를 위해 보다 정확한 도구를 찾고 있기 때문에 시장 확대의 원동력이 되고 있습니다. 이러한 요인들은 생명과학 연구에 대한 투자 증가와 함께 향후 몇 년동안 세포 계수 시장의 견고한 성장을 유지할 것으로 예상됩니다.

조사 대상 기업 예시(총 13건)

  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • BioTek Instruments, Inc.
  • Danaher Corporation
  • F. Hoffmann-La Roche AG
  • GE Healthcare
  • Horiba Ltd.
  • Merck & Co.
  • PerkinElmer, Inc.
  • Siemens Healthineers
  • Sysmex Corporation
  • Tecan Group Ltd.
  • Thermo Fisher Scientific, Inc.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 기타 유럽
  • 아시아태평양
  • 기타 지역

제4장 경쟁

LSH 24.10.04

Global Cell Counting Market to Reach US$22.0 Billion by 2030

The global market for Cell Counting estimated at US$15.3 Billion in the year 2023, is expected to reach US$22.0 Billion by 2030, growing at a CAGR of 5.3% over the analysis period 2023-2030. Cell Counting Consumables, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$12.9 Billion by the end of the analysis period. Growth in the Cell Counting Instruments segment is estimated at 4.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$4.2 Billion While China is Forecast to Grow at 5.0% CAGR

The Cell Counting market in the U.S. is estimated at US$4.2 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$3.4 Billion by the year 2030 trailing a CAGR of 5.0% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 5.2% and 4.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.3% CAGR.

Global Cell Counting Market - Key Trends and Drivers Summarized

How Is Cell Counting Advancing Research in Biotechnology and Medicine?

Cell counting has become a fundamental technique in biotechnology, life sciences, and medical research, providing critical insights into cellular behavior, growth, and response to treatments. This process involves quantifying cells in a given sample, which is essential for a wide range of applications, from assessing cell viability in drug screening to determining concentrations in cell culture. Cell counting is indispensable in fields such as cancer research, where understanding cell proliferation rates can directly influence the development of new therapies. It is also crucial in biopharmaceutical production, where accurate cell counts are necessary for consistent product yields and quality control. Moreover, cell counting is extensively used in immunology, microbiology, and hematology to monitor disease progression and the effectiveness of therapeutic interventions. Whether for research, diagnostics, or therapeutic development, the precision and efficiency of modern cell counting methods are playing a pivotal role in advancing scientific knowledge and medical innovation.

Why Is There a Growing Demand for Automated Cell Counting Technologies?

The growing demand for automated cell counting technologies stems from the need for accuracy, efficiency, and scalability in both research and clinical settings. Manual cell counting, often performed using a hemocytometer under a microscope, is labor-intensive, prone to human error, and unsuitable for high-throughput applications. In contrast, automated cell counting systems offer rapid, precise, and reproducible results, enabling researchers and clinicians to process large sample volumes in significantly less time. These systems are particularly valuable in pharmaceutical research, where the ability to rapidly analyze cell viability and proliferation across hundreds or thousands of samples is critical for drug discovery and development. Additionally, the rising complexity of biological research, especially in fields like oncology, stem cell research, and regenerative medicine, requires more sophisticated tools to handle the increasing volume of cell-based experiments. Automated cell counters equipped with advanced imaging and flow cytometry capabilities are meeting these needs by delivering high-resolution data and supporting complex assays, such as those involving heterogeneous cell populations. The integration of user-friendly software interfaces and data analysis tools further enhances the appeal of these systems, driving their adoption across laboratories and hospitals worldwide.

How Are Technological Advancements Transforming Cell Counting Techniques?

Technological advancements are transforming cell counting, improving both the accuracy and functionality of the tools available to researchers and clinicians. Innovations such as flow cytometry, image-based cell counting, and microfluidic devices are enabling more precise and high-throughput cell analysis. Flow cytometry, in particular, allows for the simultaneous counting and characterization of thousands of cells based on their physical and chemical properties, making it ideal for applications such as immunophenotyping and cancer research. Image-based cell counting, which uses advanced microscopy and software algorithms to analyze cell images, has become increasingly popular for its ability to provide detailed data on cell morphology and viability. Additionally, the emergence of label-free technologies, which allow for real-time monitoring of cell growth without the need for dyes or stains, is reducing the impact of external agents on the cells being studied, thus preserving their natural behavior. Automated systems that incorporate artificial intelligence (AI) and machine learning are further enhancing the capabilities of cell counting technologies, providing more accurate predictions and analysis of cellular behavior based on large datasets. These innovations are making cell counting faster, more reliable, and more versatile, expanding its applications in research and clinical diagnostics.

What Are the Key Growth Drivers in the Cell Counting Market?

The growth in the cell counting market is driven by several factors, including the increasing prevalence of chronic diseases, advancements in biotechnology, and the growing demand for personalized medicine. One of the primary drivers is the rising need for accurate cell analysis in disease research and diagnostics. As the global incidence of cancer, diabetes, and infectious diseases continues to increase, cell counting technologies are essential for monitoring disease progression and evaluating the effectiveness of therapies. Additionally, the expansion of the biopharmaceutical industry, particularly in the production of biologics and vaccines, has intensified the demand for precise cell counting to ensure consistent product quality. Technological advancements, such as the development of automated, high-throughput cell counting systems, are further fueling market growth by improving the speed and accuracy of research workflows. The growing trend toward personalized medicine, which requires precise cell analysis to tailor treatments to individual patients, is also boosting demand for advanced cell counting technologies. Moreover, the increasing use of stem cells in regenerative medicine and the expansion of cell-based assays in drug development are creating new opportunities for cell counting solutions. Lastly, the adoption of cell counting technologies in clinical diagnostics, particularly in hematology and immunology, continues to drive market expansion as healthcare providers seek more accurate tools for patient care. These factors, combined with the growing investment in life sciences research, are expected to sustain the robust growth of the cell counting market in the coming years.

Select Competitors (Total 13 Featured) -

  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • BioTek Instruments, Inc.
  • Danaher Corporation
  • F. Hoffmann-La Roche AG
  • GE Healthcare
  • Horiba Ltd.
  • Merck & Co., Inc.
  • PerkinElmer, Inc.
  • Siemens Healthineers
  • Sysmex Corporation
  • Tecan Group Ltd.
  • Thermo Fisher Scientific, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Global Economic Update
    • Cell Counting - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Adoption of Automated Cell Counters Expands the Addressable Market for Cell Counting Solutions
    • Here's How Advancements in Flow Cytometry Propel Innovation in Cell Counting Methods
    • Growing Use of Cell Counting in Cancer Research Strengthens Market Demand
    • Rising Focus on Stem Cell Research and Therapy Spurs Adoption of Advanced Cell Counting Techniques
    • Here's How High-Throughput Screening in Drug Discovery Generates Demand for Automated Cell Counting
    • Technological Advancements in Image-Based Cell Counting Accelerate Market Growth
    • Growing Application of Cell Counting in Biologics and Vaccine Production Drives Demand
    • Rising Investments in Biotechnology and Life Sciences Propel Growth in Cell Counting Markets
    • Expanding Use of Cell Counting in Immunology and Infectious Disease Research Creates New Opportunities
    • Rising Incidence of Chronic Diseases Drives the Need for Accurate Cell Quantification in Clinical Diagnostics
    • Growing Adoption of Microfluidic Technologies Enhances Accuracy and Efficiency in Cell Counting
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Cell Counting Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Cell Counting by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Cell Counting by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Cell Counting by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Consumables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Clinical Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Clinical Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Clinical Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Pharma & Biotech Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Cell Counting Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for Cell Counting by Type - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Cell Counting by Type - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: USA 16-Year Perspective for Cell Counting by Type - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2014, 2024 & 2030
    • TABLE 29: USA Recent Past, Current & Future Analysis for Cell Counting by End-Use - Research Institutes, Hospitals, Clinical Laboratories, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Cell Counting by End-Use - Research Institutes, Hospitals, Clinical Laboratories, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: USA 16-Year Perspective for Cell Counting by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Hospitals, Clinical Laboratories, Pharma & Biotech Companies and Other End-Uses for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Cell Counting by Type - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Cell Counting by Type - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: Canada 16-Year Perspective for Cell Counting by Type - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2014, 2024 & 2030
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Cell Counting by End-Use - Research Institutes, Hospitals, Clinical Laboratories, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Cell Counting by End-Use - Research Institutes, Hospitals, Clinical Laboratories, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: Canada 16-Year Perspective for Cell Counting by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Hospitals, Clinical Laboratories, Pharma & Biotech Companies and Other End-Uses for the Years 2014, 2024 & 2030
  • JAPAN
    • Cell Counting Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Cell Counting by Type - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Cell Counting by Type - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: Japan 16-Year Perspective for Cell Counting by Type - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2014, 2024 & 2030
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Cell Counting by End-Use - Research Institutes, Hospitals, Clinical Laboratories, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Cell Counting by End-Use - Research Institutes, Hospitals, Clinical Laboratories, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: Japan 16-Year Perspective for Cell Counting by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Hospitals, Clinical Laboratories, Pharma & Biotech Companies and Other End-Uses for the Years 2014, 2024 & 2030
  • CHINA
    • Cell Counting Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 44: China Recent Past, Current & Future Analysis for Cell Counting by Type - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Cell Counting by Type - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: China 16-Year Perspective for Cell Counting by Type - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2014, 2024 & 2030
    • TABLE 47: China Recent Past, Current & Future Analysis for Cell Counting by End-Use - Research Institutes, Hospitals, Clinical Laboratories, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Cell Counting by End-Use - Research Institutes, Hospitals, Clinical Laboratories, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: China 16-Year Perspective for Cell Counting by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Hospitals, Clinical Laboratories, Pharma & Biotech Companies and Other End-Uses for the Years 2014, 2024 & 2030
  • EUROPE
    • Cell Counting Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Cell Counting by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Cell Counting by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Cell Counting by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Cell Counting by Type - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Cell Counting by Type - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Cell Counting by Type - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2014, 2024 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Cell Counting by End-Use - Research Institutes, Hospitals, Clinical Laboratories, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Cell Counting by End-Use - Research Institutes, Hospitals, Clinical Laboratories, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: Europe 16-Year Perspective for Cell Counting by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Hospitals, Clinical Laboratories, Pharma & Biotech Companies and Other End-Uses for the Years 2014, 2024 & 2030
  • FRANCE
    • Cell Counting Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 59: France Recent Past, Current & Future Analysis for Cell Counting by Type - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Cell Counting by Type - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: France 16-Year Perspective for Cell Counting by Type - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2014, 2024 & 2030
    • TABLE 62: France Recent Past, Current & Future Analysis for Cell Counting by End-Use - Research Institutes, Hospitals, Clinical Laboratories, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Cell Counting by End-Use - Research Institutes, Hospitals, Clinical Laboratories, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: France 16-Year Perspective for Cell Counting by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Hospitals, Clinical Laboratories, Pharma & Biotech Companies and Other End-Uses for the Years 2014, 2024 & 2030
  • GERMANY
    • Cell Counting Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Cell Counting by Type - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Cell Counting by Type - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: Germany 16-Year Perspective for Cell Counting by Type - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2014, 2024 & 2030
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Cell Counting by End-Use - Research Institutes, Hospitals, Clinical Laboratories, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Cell Counting by End-Use - Research Institutes, Hospitals, Clinical Laboratories, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: Germany 16-Year Perspective for Cell Counting by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Hospitals, Clinical Laboratories, Pharma & Biotech Companies and Other End-Uses for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Cell Counting by Type - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Cell Counting by Type - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: Italy 16-Year Perspective for Cell Counting by Type - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2014, 2024 & 2030
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Cell Counting by End-Use - Research Institutes, Hospitals, Clinical Laboratories, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Cell Counting by End-Use - Research Institutes, Hospitals, Clinical Laboratories, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: Italy 16-Year Perspective for Cell Counting by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Hospitals, Clinical Laboratories, Pharma & Biotech Companies and Other End-Uses for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Cell Counting Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 77: UK Recent Past, Current & Future Analysis for Cell Counting by Type - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Cell Counting by Type - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: UK 16-Year Perspective for Cell Counting by Type - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2014, 2024 & 2030
    • TABLE 80: UK Recent Past, Current & Future Analysis for Cell Counting by End-Use - Research Institutes, Hospitals, Clinical Laboratories, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Cell Counting by End-Use - Research Institutes, Hospitals, Clinical Laboratories, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: UK 16-Year Perspective for Cell Counting by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Hospitals, Clinical Laboratories, Pharma & Biotech Companies and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 83: Rest of Europe Recent Past, Current & Future Analysis for Cell Counting by Type - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Rest of Europe Historic Review for Cell Counting by Type - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Rest of Europe 16-Year Perspective for Cell Counting by Type - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2014, 2024 & 2030
    • TABLE 86: Rest of Europe Recent Past, Current & Future Analysis for Cell Counting by End-Use - Research Institutes, Hospitals, Clinical Laboratories, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Rest of Europe Historic Review for Cell Counting by End-Use - Research Institutes, Hospitals, Clinical Laboratories, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Rest of Europe 16-Year Perspective for Cell Counting by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Hospitals, Clinical Laboratories, Pharma & Biotech Companies and Other End-Uses for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Cell Counting Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 89: Asia-Pacific Recent Past, Current & Future Analysis for Cell Counting by Type - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Asia-Pacific Historic Review for Cell Counting by Type - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Asia-Pacific 16-Year Perspective for Cell Counting by Type - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2014, 2024 & 2030
    • TABLE 92: Asia-Pacific Recent Past, Current & Future Analysis for Cell Counting by End-Use - Research Institutes, Hospitals, Clinical Laboratories, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Asia-Pacific Historic Review for Cell Counting by End-Use - Research Institutes, Hospitals, Clinical Laboratories, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Asia-Pacific 16-Year Perspective for Cell Counting by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Hospitals, Clinical Laboratories, Pharma & Biotech Companies and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 95: Rest of World Recent Past, Current & Future Analysis for Cell Counting by Type - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Rest of World Historic Review for Cell Counting by Type - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Rest of World 16-Year Perspective for Cell Counting by Type - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2014, 2024 & 2030
    • TABLE 98: Rest of World Recent Past, Current & Future Analysis for Cell Counting by End-Use - Research Institutes, Hospitals, Clinical Laboratories, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Rest of World Historic Review for Cell Counting by End-Use - Research Institutes, Hospitals, Clinical Laboratories, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Rest of World 16-Year Perspective for Cell Counting by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Hospitals, Clinical Laboratories, Pharma & Biotech Companies and Other End-Uses for the Years 2014, 2024 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제